Biodegradable Long-Acting Injectables: Platform Technology and Industrial Challenges.

Handb Exp Pharmacol

Technical Research and Development, Novartis Pharma AG, Basel, Switzerland.

Published: April 2024

Long-acting injectables have been used to benefit patients with chronic diseases. So far, several biodegradable long-acting platform technologies including drug-loaded polymeric microparticles, implants (preformed and in situ forming), oil-based solutions, and aqueous suspension have been established. In this chapter, we summarize all the marketed technology platforms and discuss their challenges regarding development including but not limited to controlling drug release, particle size, stability, sterilization, scale-up manufacturing, etc. Finally, we discuss important criteria to consider for the successful development of long-acting injectables.

Download full-text PDF

Source
http://dx.doi.org/10.1007/164_2023_651DOI Listing

Publication Analysis

Top Keywords

long-acting injectables
12
biodegradable long-acting
8
injectables platform
4
platform technology
4
technology industrial
4
industrial challenges
4
challenges long-acting
4
injectables benefit
4
benefit patients
4
patients chronic
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!